definiens: means the program described in the Predecessor Agreement and this Agreeme nt in which the parties have col1abormed and will continue to collaborate . in each case . 10 identify . characterize and C, lrry OLit the Biotherapeutics Research, Development and Commercialization under the Predecessor Agreement, and the Biotherapeuti cs Research under this Agreement . of Antibodies ( and, if appropriate, Antisense Compounds ) that act through . and Proteins that are encoded by, Program Targets that have nol become Released Targets or Reverted Targets for use in the Field . For clarity, the Collaboratio n shall be deemed to include all activities conducted by the pnrties and their respective AiTilimes during the Collaboration Tcnll relating to the identification, clmraeterization and carrying out the Biotherapcutics Research or Amibociies ( and, if appropri < lte, AllIiscnse Compounds ) that act through